BodyTel Scientific, Inc. (OTCBB: BDYT), a company focused on the development of innovative wireless healthcare products, announced the formation of BodyTel Europe GmbH, a wholly owned subsidiary of BodyTel Scientific, Inc., in Bad Wildungen, Germany. BodyTel Europe will serve as the center for all sales and marketing related functions for Europe, the Middle East and Africa (EMEA). Stefan Schraps, Chief Executive Officer and President of BodyTel Scientific, Inc., will be based at the new office and will serve as CEO (Geschaeftsfuehrer) of the limited liability company under German law.
BodyTel Europe has begun recruiting qualified sales and administrative personnel for the upcoming launch of GlucoTel, the first and only diabetes self-management system with integrated Bluetooth. Management believes, based on the development of the GlucoTel system, that now is an opportune time to start hiring a competent sales and marketing team.
BodyTel Scientific, Inc., CEO, Stefan Schraps, commented, “We are making tremendous strides in the development of our GlucoTel product and we are confident to be on schedule for product launch in Fall 2007. With the launch of our product nearing, and as worldwide partnerships are executed, it is extremely important that our European presence be firmly established.”
The GlucoTel Meter is the first and only blood glucose monitoring device in the world with integrated Bluetooth(TM) technology. The meter is part of the GlucoTel system, which is a complete telemedical diabetes self-management system supporting patients and doctors in the treatment of diabetes and its secondary complications. The GlucoTel blood glucose meter collects blood sugar readings and sends them to the patient's mobile phone via Bluetooth. Afterwards, the data is automatically sent to a secure Internet database via SMS and is centrally held there long-term. GlucoTel enables involvement of the patients in the treatment of diabetes, thereby improves the information basis and communication between doctor and patient and thus contributes to the course of therapy.
About BodyTel Scientific, Inc.
BodyTel Scientific, Inc. is a company focused on the development of innovative wireless health monitoring products. Please visit www.bodytel.com for more company information.
Forward-Looking Statements
Statements regarding the Company's business which are not historical facts are "forward-looking statements" that involve risks and uncertainties that could cause actual results to differ materially from the potential results discussed in the forward-looking statements. Forward-looking statements in this press release include that BodyTel Europe will serve as the center for all sales and marketing related functions for Europe, the Middle East and Africa, that Management believes, based on the development of the GlucoTel system, that now is an opportune time to start hiring a competent sales and marketing team, and that we are confident to be on schedule for product launch in Fall 2007. Actual results may differ materially from those currently anticipated due to a number of factors as we may find that our products must compete with cheaper or better products; we may not be able to retain key employees; a bigger market may not develop for our products and we may not be able to continue to attract new customers; we may face litigation if our technology fails to work when required; our intellectual property may be attacked and defeated in court proceedings; our patent and FDA/CE filings may be rejected by the patent offices and regulators; other companies may discover and develop better or cheaper technologies that would render our products obsolete and we may not have sufficient funding to further develop and/or market our technology. Readers are directed to the BodyTel Scientific, Inc.’s reports as filed with the U.S. Securities and Exchange Commission from time to time, including but not limited to its 8-K filed December 14, 2006 under our prior name Sellcell.net which outlined the company’s current business for further information and factors that may affect BodyTel Scientific Inc.’s business and results of operations as well as the Company’s form 10-KSB filed on June 20, 2007. BodyTel Scientific Inc. undertakes no obligations to publicly update any forward-looking statements to reflect future events or circumstances.